RefleXion Medical Radiotherapy System - System Label: "*** refleXion REF RXM1000 ***" Phys...

FDA Device Recall #Z-0470-2022 — Class II — November 24, 2021

Recall Summary

Recall Number Z-0470-2022
Classification Class II — Moderate risk
Date Initiated November 24, 2021
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Reflexion Medical, Inc.
Location Hayward, CA
Product Type Devices
Quantity 3 devices

Product Description

RefleXion Medical Radiotherapy System - System Label: "*** refleXion REF RXM1000 ***" Physics Guide/Treatment Delivery User Manual/Treatment Planning User Manual: "RefleXion X1 Model: RXM1000"

Reason for Recall

Due to dose discrepancy when delivering a plan to a patient in a Non-HFS (Head First Supine) orientation specifically in Feet First Supine (FFS).

Distribution Pattern

U.S. Nationwide distribution in the states of CA and TX

Lot / Code Information

Model: RXM1000 Serial Numbers/UDI Codes: X11001 / (01)00860003983805(11)210125(21)X11001 X11002 / (01)00860003983805(11)210324(21)X11002 X11003 / (01)00860003983805(11)210524(21)X11003

Other Recalls from Reflexion Medical, Inc.

Recall # Classification Product Date
Z-1656-2026 Class II RefleXion X1 Radiotherapy System Model RXM1000,... Feb 9, 2026
Z-2486-2025 Class II RefleXion X1 Model RXM1000 UDI Codes: (01)008... Jul 22, 2025
Z-1933-2024 Class II RefleXion X1 Radiotherapy System Model RXM1000 ... Apr 16, 2024

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.